异基因造血细胞移植后急性移植物抗宿主病发病时可识别的预后因素。 - Suppr | 超能文献

Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.

作者信息

Remberger Mats

机构信息

Karolinska Institutet, Clinical Immunology, F79 Karolinska University Hospital, Huddinge, SE-141 86, Stockholm, Sweden.

出版信息

Haematologica. 2005 Jul;90(7):870.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Haematologica. 2005 Jul;90(7):870.

2

Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Haematologica. 2005 Jul;90(7):939-48.

3

Emerging drugs for acute graft-versus-host disease.

Expert Opin Emerg Drugs. 2009 Jun;14(2):219-32. doi: 10.1517/14728210903018891.

4

Biology and management of chronic graft-versus-host disease.

Cancer Treat Res. 2009;144:277-98. doi: 10.1007/978-0-387-78580-6_12.

5

Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.

Am J Dermatopathol. 2007 Feb;29(1):1-6. doi: 10.1097/01.dad.0000246173.96318.0c.

6

Allogeneic hematopoietic stem cell transplantation against recurrent rhabdomyosarcoma.

J Pediatr Hematol Oncol. 2011 Jan;33(1):e35-8. doi: 10.1097/MPH.0b013e3181e7ddc5.

7

A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.

Haematologica. 2008 Feb;93(2):265-72. doi: 10.3324/haematol.11672.

8

Cytomegalovirus infection and chronic graft-versus-host disease are significant predictors of renal failure after allogeneic hematopoietic stem cell transplantation.

Haematologica. 2005 Apr;90(4):569-70.

9

Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.

Biol Blood Marrow Transplant. 2008 May;14(5):510-7. doi: 10.1016/j.bbmt.2008.02.008.

10

Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan.

Am J Hematol. 2007 Oct;82(10):873-80. doi: 10.1002/ajh.20977.